Anti-Obesity Drugs Flashcards
What percentage of Australians are overweight or obese?
67%
What percentage of overweight or obese account for the total disease burden in Australia?
8.4% - the 2nd leading risk factor behind tobacco use
What diseases are reported at higher rates in overweight and obese people?
Arthritis Back pain/problems Cancer Diabetes Cardiovascular disease
What socioeconomic groups is overweight/obesity more commonly in?
- Lower socioeconomic
- Rural populations
- Some immigrant groups
- Aboriginal and Torres Strait Islander people
Definition of overweight and obesity?
WHO defined them as abnormal or excessive fat accumulation that presents a risk to health
Between 19080 - 2015 how many countries did obesity prevalence double in?
73 countries
By the year 2030 what percentage of the worlds population will be overweight or obese?
58%
What is the desirable BMI range for young adults?
18.5 - 24.9 kg/m2
What BMI range is overweight defined as?
25 - 30 kg/m2.5
What waist circumference is classified as a adverse risk?
> 94cm in men
>80cm in women
What diseases are associated with overweight and obesity?
- Cardiovascular (CHD, Stroke, CKD, HTN)
- Respiratory (Asthma)
- Mechanical (OA, Back pain)
- Metabolic (DM, Gout)
- Cancer (Breast, Ovary, Bowel, Esophageal, Liver, Kidney, Pancreatic, Uterine, Leukemia, Thyroid, Gallbladder)
- Neurological (Dementia)
- GI (Gallstones)
What stimuli can trigger the eating center?
Tastes Smells Low BGL Marijuana Low temperatures
What stimuli can inhibit eating?
High ambient temps
Gut distention
Malaise
Sympathetic nervous system activity
What hypothalamic peptide is a potent stimulant of feeding?
Neuropeptide Y (NPY) (produced in the gut and inhibits the satiety center)
What is secreted by the stomach to stimulate appetite?
Ghrelin (blood levels of ghrelin fluctuate, decreasing after a meal and increasing prior to eating)
What neurotransmitters inhibit eating?
Monoamine neurotransmitters = noradrenaline and serotonin
What hormone stimulates the satiety center in the hypothalamus?
Cholecystokinin (CCK) = secreted in the GI system when triglycerides are digested in the small intestine
What tells the brain about body fat levels?
Adipose cells provide the brain with information about body fat levels through the secretion of leptin
Where are leptin receptors located?
Hypothalamus feeding centers of the brain
leptin increases energy expenditure
What drugs for other illnesses have been identified to promote weight loss?
- Bupropion
- Fluoxetine
- Metformin
What is the name of drugs that reduce food intake?
Anorectic (anorexic)
How do serotonergic drugs work for weight loss?
Causes increased secretion of serotonin and is believed to act mainly in the hypothalamus, the appetite and satiety center of the brain.
What serotonergic drugs were approved in 1973 and 1996 in the USA?
Fenfluramine (Pondimin)
Dexfenfluramine (Redux)
It became common practice to prescribe one of two drugs with phentermine (“fen-phen” or dexfen-phen”).
What happened in 1997 from long term Fen-Phen treatment?
It was associated with valvular lesion, with incompetence of the aortic and mitral valves
What was also reported to significantly increase from Fen-Phen?
Primary Pulmonary Hypertension
How do noradrenergic drugs work? (Phentermine - duromine)
- This group of drugs releases noradrenaline or blocks its re-uptake into the neurons of the hypothalamus.
- The increase in noradrenaline in the brain areas that control appetite delays the onset of hunger sensation and decreases the drive to eat
- Phentermine (Duromine) stimulates release of noradrenaline from the presynaptic granules.
- Drugs in this group include amphetamines. Amphetamines are no longer recommended because of strong stimulatory properties and addictive potential.
Adverse effects of noradrenergic drugs? (Phentermine - duromine)
- The most common side effects are: headache, insomnia, nervousness and irritability.
- Other side effects include: palpitations, increased heart rate (>100bpm), high blood pressure.
Who should not take Phentermine (duromine - noradrenergic)?
Individuals with hyperthyroidism, glaucoma, advanced arteriosclerosis, htn, history of drug abuse.